Protein tolerance to standard and high protein meals in patients with liver cirrhosis
- PMID: 28588751
- PMCID: PMC5437611
- DOI: 10.4254/wjh.v9.i14.667
Protein tolerance to standard and high protein meals in patients with liver cirrhosis
Abstract
Aim: To investigate the plasma amino acid response and tolerance to normal or high protein meals in patients with cirrhosis.
Methods: The plasma amino acid response to a 20 g mixed protein meal was compared in 8 biopsy-proven compensated cirrhotic patients and 6 healthy subjects. In addition the response to a high protein meal (1 g/kg body weight) was studied in 6 decompensated biopsy-proven cirrhotics in order to evaluate their protein tolerance and the likelihood of developing hepatic encephalopathy (HE) following a porto-caval shunt procedure. To test for covert HE, the "number connection test" (NCT) was done on all patients, and an electroencephalogram was recorded in patients considered to be at Child-Pugh C stage.
Results: The changes in plasma amino acids after a 20 g protein meal were similar in healthy subjects and in cirrhotics except for a significantly greater increase (P < 0.05) in isoleucine, leucine and tyrosine concentrations in the cirrhotics. The baseline branched chain amino acids/aromatic amino acids (BCAA/AAA) ratio was higher in the healthy persons and remained stable-but it decreased significantly after the meal in the cirrhotic group. After the high protein meal there was a marked increase in the levels of most amino acids, but only small changes occurred in the levels of taurine, citrulline, cysteine and histidine.The BCAA/AAA ratio was significantly higher 180 and 240 min after the meal. Slightly elevated basal plasma ammonia levels showed no particular pattern. Overt HE was not observed in any patients.
Conclusion: Patients with stable liver disease tolerate natural mixed meals with a standard protein content. The response to a high protein meal in decompensated cirrhotics suggests accumulation of some amino acids but it did not precipitate HE. These results support current nutritional guidelines that recommend a protein intake of 1.2-1.5 g/kg body weight/day for patients with cirrhosis.
Keywords: Amino acids; Branched chain amino acids; Cirrhosis; Diet; Fischer’s ratio; Liver; Nutrition; Protein; Tolerance.
Conflict of interest statement
Conflict-of-interest statement: There are no conflicts of interest arising from this work.
Figures





Similar articles
-
Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.J Gastroenterol Hepatol. 2007 Aug;22(8):1241-8. doi: 10.1111/j.1440-1746.2006.04620.x. J Gastroenterol Hepatol. 2007. PMID: 17688664 Clinical Trial.
-
Dynamic Elevation of Aromatic Amino Acids in Hepatitis C Virus-Induced Cirrhosis After a Standard Meal.Clin Transl Gastroenterol. 2024 Mar 1;15(3):e00666. doi: 10.14309/ctg.0000000000000666. Clin Transl Gastroenterol. 2024. PMID: 38088382 Free PMC article.
-
The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics.Rev Invest Clin. 1992 Oct-Dec;44(4):513-8. Rev Invest Clin. 1992. PMID: 1485030
-
Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.Nutrition. 2015 Jan;31(1):14-20. doi: 10.1016/j.nut.2014.03.016. Epub 2014 Mar 30. Nutrition. 2015. PMID: 25220875 Review.
-
Aromatic amino acid metabolism during liver failure.J Nutr. 2007 Jun;137(6 Suppl 1):1579S-1585S; discussion 1597S-1598S. doi: 10.1093/jn/137.6.1579S. J Nutr. 2007. PMID: 17513430 Review.
Cited by
-
Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Nutrients. 2024 Feb 26;16(5):658. doi: 10.3390/nu16050658. Nutrients. 2024. PMID: 38474786 Free PMC article. Review.
-
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489. World J Hepatol. 2019. PMID: 31293718 Free PMC article. Review.
-
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.J Clin Exp Hepatol. 2021 Jan-Feb;11(1):97-143. doi: 10.1016/j.jceh.2020.09.003. Epub 2020 Oct 1. J Clin Exp Hepatol. 2021. PMID: 33679050 Free PMC article. Review.
-
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2. Am J Gastroenterol. 2025. PMID: 40314389
-
Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study.Health Qual Life Outcomes. 2021 May 17;19(1):148. doi: 10.1186/s12955-021-01787-9. Health Qual Life Outcomes. 2021. PMID: 34001156 Free PMC article.
References
-
- Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976;80:77–91. - PubMed
-
- Tavill AS. Protein metabolism and the liver. In: Liver and biliary disease, Wright R, Alberti KGMM, Karran S (eds). London, Saunders; 1985. pp. 87–113.
-
- Marchesini G, Bianchi GP, Vilstrup H, Checchia GA, Patrono D, Zoli M. Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. J Hepatol. 1987;4:108–117. - PubMed
-
- Kato A, Suzuki K. How to select BCAA preparations. Hepatol Res. 2004;30S:30–35. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources